E6/E7 RNA liposomal vaccine (BioNTech RNA/Ganymed)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameE6/E7 RNA liposomal vaccine (BioNTech RNA/Ganymed)
Drug Alias NameE7-RNA-LPXE6/E7 RNA(LIP)
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionProtein E7 modulatorsProtein E6 modulators
TargetsProtein E7Protein E6
Therapy Area/IndicationsSquamous Cell Carcinoma of Head and Neck
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBiontech Se
China Registration ClassN/A

Develop Information

Active CompaniesAstellas Pharma IncBiontech Se
Inactive CompaniesN/A
Active IndicationsSquamous Cell Carcinoma of Head and Neck
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A